Adaptive Biotechnologies Announces Preliminary, Unaudited 2021 Revenue Results and CFO TransitionGlobeNewsWire • 01/10/22
Updated: Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/04/22
Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 12/29/21
Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ® Assay in Patients with Blood Cancers at the 63rd ASH Annual MeetingGlobeNewsWire • 12/13/21
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual MeetingGlobeNewsWire • 12/02/21
Adaptive Biotechnologies Receives Updated Medicare Coverage for its Minimal Residual Disease (MRD) Assay, clonoSEQ® for Blood Cancer PatientsGlobeNewsWire • 11/11/21
Adaptive Biotechnologies Corporation (ADPT) CEO Chad Robins on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/03/21
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 3, 2021GlobeNewsWire • 10/06/21
Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme DiseaseGlobeNewsWire • 10/02/21
Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation StatusGlobeNewsWire • 09/30/21
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in SeattleGlobeNewsWire • 09/21/21
Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021GlobeNewsWire • 09/16/21
Adaptive Biotechnologies to Present at the Morgan Stanley Global Healthcare ConferenceGlobeNewsWire • 09/07/21
Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study AccessPRNewsWire • 08/10/21
Adaptive Biotechnologies Corporation (ADPT) CEO Chad Robins on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Earnings Preview: Adaptive Biotechnologies (ADPT) Q2 Earnings Expected to DeclineZacks Investment Research • 07/28/21
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021GlobeNewsWire • 07/12/21